Welcome to our dedicated page for Coca-Cola Europacific Partners Plc SEC filings (Ticker: CCEP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Coca-Cola Europacific Partners plc filings document a foreign private issuer with ordinary shares and a multinational beverage bottling and distribution business. Its Form 20-F annual reports cover audited results, operating performance, segment activity, risk factors, governance and disclosures tied to its consumer goods operations across 31 countries.
CCEP’s Form 6-K reports furnish trading updates, interim dividend declarations, AGM and proxy materials, amendments to long-term incentive plan rules, board committee changes, share repurchase transactions, total voting rights and capital, and PDMR shareholding notices. The filing record also includes incorporation of certain 6-K disclosures by reference into employee share plan registration statements.
Coca-Cola Europacific Partners plc (CCEP) provides an update on shareholder voting at its 2025 Annual General Meeting, focusing on the Rule 9 waiver linked to its share buyback authority. All resolutions at the AGM were passed, but the Rule 9 Waiver Resolution received lower support, with 74.95% of votes cast in favour, compared with very high approval for related buyback authorities in resolutions 27 and 28, at 99.22% and 98.22% respectively.
The Rule 9 waiver allows CCEP to continue repurchasing its own shares without triggering a mandatory takeover offer by Olive Partners, S.A. if its ownership percentage rises due to buybacks. The Board links this to its previously announced commitment to return up to €1bn to shareholders via share buybacks and states that buybacks are a core element of its capital allocation framework. The Board acknowledges shareholder concerns about Rule 9 waivers, notes ongoing engagement with investors, and says it continues to consider alternative ways of returning capital.
Coca-Cola Europacific Partners plc (CCEP) reports a series of share repurchases in November 2025 under its share buyback programme of up to EUR 1 billion of ordinary shares. The company states that all repurchased shares will be cancelled.
On 11 November 2025, CCEP purchased 71,676 ordinary shares on US trading venues at prices between USD 91.9900 and USD 93.3600 per share, and 34,000 ordinary shares on London trading venues. On 12 November 2025, it bought 69,878 ordinary shares on US trading venues and 34,000 on London venues, followed by 70,701 and 20,000 ordinary shares respectively on 13 November 2025.
Further purchases included 72,285 ordinary shares on US trading venues and 15,350 on London venues on 14 November 2025, and 72,183 ordinary shares on US trading venues on 17 November 2025. The repurchases took place across Nasdaq and other US venues, as well as the London Stock Exchange, CBOE Europe and Aquis.
Coca-Cola Europacific Partners (CCEP) filed a Form 6-K reporting daily share repurchases carried out between 4 and 10 November 2025 under its buyback programme, under which the company expects to repurchase up to EUR 1 billion of ordinary shares. All repurchased shares will be cancelled. Purchases were executed on US Trading Venues (including Nasdaq) via Jefferies LLC and on London Trading Venues via Jefferies International Limited.
Disclosed daily activity: on 4 Nov, 75,415 shares on US venues and 34,000 on London venues; on 5 Nov, 74,660 (US) and 34,000 (London); on 6 Nov, 73,944 (US) and 34,000 (London); on 7 Nov, 73,606 (US) and 33,958 (London); on 10 Nov, 71,388 (US) and 32,000 (London). The disclosures include venue-level highest, lowest and volume‑weighted average prices for each day.
Coca-Cola Europacific Partners filed a Form 6-K with a Q3 trading update and an interim dividend declaration. Reported revenue was €5,410m in Q3, up 1.0%, with adjusted comparable FXN revenue up 3.2%. Year-to-date reported revenue reached €15,684m (up 3.3%), and adjusted comparable FXN revenue grew 2.7%.
Q3 adjusted comparable volume increased 0.4% and revenue per unit case rose 2.7%. Europe delivered €4,194m of Q3 revenue with adjusted comparable revenue per unit case up 3.4%, while APS posted €1,216m with FXN revenue down 0.2%. Management noted slightly lower transactions than volume due to weather in the Philippines and softer consumer sentiment in Europe.
The Board declared a second-half interim dividend of €1.25 per share, payable on 3 December 2025 to shareholders of record on 14 November 2025, resulting in a full-year dividend of €2.04 per share and maintaining an approximately 50% dividend payout ratio. Jefferies International Limited was appointed joint corporate broker alongside BNP Paribas and Deutsche Bank.
Coca-Cola Europacific Partners (CCEP) reported a solid third quarter and reaffirmed full‑year guidance. Q3 reported revenue was €5,410m (up 1.0%), with adjusted comparable FX‑neutral revenue up 3.2%. Adjusted comparable volume rose 0.4%, and revenue per unit case increased 2.7%. Europe volume grew 0.9% while APS declined 0.6%. Year‑to‑date reported revenue reached €15,684m (up 3.3%), with adjusted comparable FX‑neutral revenue up 2.7%.
CCEP declared a second‑half interim dividend of €1.25 per share, payable on 3 December 2025 to shareholders of record on 14 November 2025, resulting in a full‑year dividend per share of €2.04 and maintaining an approximately 50% payout ratio. Management reaffirmed FY25 outlook: revenue growth of 3%–4% (adjusted comparable, FX‑neutral), cost of sales per unit case growth of about 2.5%, operating profit growth of about 7%, comparable effective tax rate around 26%, capex near 5% of revenue, and comparable free cash flow of at least €1.7bn. The €1bn share buyback is to be completed during calendar 2025, with about €809m completed to date. CCEP noted an expected full‑year FX headwind of ~180 bps to revenue and ~200 bps to operating profit.
Coca-Cola Europacific Partners (CCEP) furnished a 6-K detailing recent share repurchases under its buyback programme. The company repurchased ordinary shares on multiple trading days between 28 October and 3 November 2025 across US and London venues, and stated that all repurchased shares will be cancelled. The purchases form part of the Programme announced on 14 February 2025, under which CCEP expects to repurchase up to EUR 1 billion of ordinary shares in aggregate.
Examples from the period include 71,865 shares on US venues and 34,000 on London venues on 28 October, and 73,242 on US venues and 34,000 on London venues on 3 November. Transactions were executed by Jefferies LLC (US) and Jefferies International Limited (London), with disclosures made in line with the Market Abuse Regulation. The company reiterated that these transactions do not constitute an offer or solicitation for securities.
Coca-Cola Europacific Partners (CCEP) furnished a 6-K summarizing October disclosures under the FCA’s DTR rules. The company issued a correction on October 10 to its prior notice and confirmed the figures for September month-end. As at 30 September 2025, CCEP had 453,908,343 ordinary shares in issue, each with one vote, and no shares in treasury.
CCEP also reported routine PDMR dealings. Transactions included small share acquisitions through the Employee Share Purchase Plan and UK Share Plan, and limited sales solely to fund tax liabilities, with disclosed trade prices such as USD $91.450000 on October 27.
As at 31 October 2025, CCEP had 451,672,150 ordinary shares in issue, each with one vote, and no shares in treasury. These totals provide the denominator for notification thresholds under the FCA’s Disclosure Guidance and Transparency Rules.
Coca-Cola Europacific Partners (CCEP) filed a Form 6-K detailing daily transactions in its own shares under its buyback programme. Between October 21–27, 2025, CCEP repurchased ordinary shares on U.S. trading venues each day: 72,112 (Oct 21), 70,994 (Oct 22), 70,903 (Oct 23), 71,116 (Oct 24) and 71,769 (Oct 27). On October 27, it also bought 34,000 shares across London venues (27,400 LSE; 1,000 CXE; 5,500 BXE; 100 Aquis). The repurchased shares will be cancelled.
The purchases form part of the Programme announced on 14 February 2025, under which the Company expects to repurchase up to EUR 1 billion of ordinary shares in aggregate. Reported price metrics included U.S. venue volume-weighted average prices such as USD 91.3525 (Oct 21) and USD 91.4596 (Oct 27), and London venue VWAPs on Oct 27 around GBP 68.66–68.67.
Coca-Cola Europacific Partners (CCEP) filed a Form 6-K reporting ongoing share repurchases under its buyback programme. The company executed daily market purchases to retire stock, stating that the repurchased ordinary shares will be cancelled. Purchases included: 14 Oct — 74,296 shares on US venues and 31,397 on London venues; 15 Oct — 73,645 (US) and 34,000 (London); 16 Oct — 73,936 (US) and 32,898 (London); 17 Oct — 73,771 (US) and 21,752 (London); 20 Oct — 72,609 (US) and 0 (London).
These transactions form part of the programme announced on 14 February 2025, under which CCEP expects to repurchase up to EUR 1 billion of ordinary shares in aggregate. Reported trade prices during the period ranged from USD 87.6700 to USD 91.1800 on US venues and from GBP 66.0000 to GBP 67.6000 on London venues. The company provided links to detailed schedules for each trading day.
Coca-Cola Europacific Partners (CCEP) reported a series of on-market share repurchases across multiple trading venues between 7 and 13 October 2025. These transactions were executed under its share buyback programme announced on 14 February 2025, under which the company expects to repurchase up to EUR 1 billion of ordinary shares. The repurchased shares will be cancelled.
Activity included, for example, purchases on 7 October of 75,223 ordinary shares on US trading venues and 34,000 on London venues, and on 8 October of 74,812 on US venues and 34,000 on London venues. Reported volume-weighted average prices over the period included USD 88.0173 and GBP 66.3761 on 10 October, and the highest per-share prices reached USD 89.2900 and GBP 66.8000 on certain days.
Transactions were carried out via Nasdaq and other applicable US trading venues, and via the London Stock Exchange, CBOE Europe (BXE/CXE) and Aquis. Detailed trade schedules are available through the linked disclosures.